D-0260-2024 Class II Terminated
FDA drug recall D-0260-2024 was initiated by Strides Pharma Inc. on Dec 29, 2023 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Jul 1, 2025). Affected quantity: 396 50-count bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- Jan 31, 2024
- Initiation Date
- Dec 29, 2023
- Termination Date
- Jul 1, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 396 50-count bottles
Product Description
Methoxsalen Capsules, USP 10mg, 50-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India. Distributed by:Strides Pharma Inc. East Brunswick, NJ 08816, NDC 64380-752-16
Reason for Recall
Failed Dissolution Specifications
Distribution Pattern
Nationwide in the USA
Code Information
Lot #: 7253092B, Exp Date 09/30/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0260-2024
- openFDA file date
- Nov 3, 2026
- Loaded by RegDataLab
- Nov 4, 2026